Assenagon Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-146,082	Closed	-$12.2M	–	1368
2024 Q4	$12.2M	Sell	146,082 -86,851	-37%	-$7.14M	0.02%	465
2024 Q3	$17M	Sell	232,933 -109,910	-32%	-$8.26M	0.03%	385
2024 Q2	$23.5M	Sell	342,843 -306,974	-47%	-$21.3M	0.05%	267
2024 Q1	$45M	Sell	649,817 -114,157	-15%	-$7.85M	0.11%	154
2023 Q4	$54.7M	Buy	763,974 +275,368	+56%	+$15.8M	0.15%	124
2023 Q3	$25.5M	Buy	488,606 +298,303	+157%	+$17.4M	0.08%	206
2023 Q2	$12M	Buy	190,303 +57,492	+43%	+$3.58M	0.04%	321
2023 Q1	$7.19M	Buy	132,811 +52,583	+66%	+$2.54M	0.03%	467
2022 Q4	$4.25M	Buy	80,228 +32,806	+69%	+$1.64M	0.02%	569
2022 Q3	$2.21M	Buy	47,422 +8,232	+21%	+$430K	0.01%	678
2022 Q2	$2.24M	Sell	39,190 -53,510	-58%	-$3.03M	0.01%	796
2022 Q1	$5.67M	Sell	92,700 -35,411	-28%	-$1.84M	0.02%	505
2021 Q4	$6.71M	Buy	+128,111	New	+$5.38M	0.02%	437
2021 Q2	–	Sell	-208,301	Closed	-$7.07M	–	1440
2021 Q1	$7.07M	Buy	208,301 +4,313	+2%	+$150K	0.03%	423
2020 Q4	$6.49M	Sell	203,988 -271,906	-57%	-$7.15M	0.03%	317
2020 Q3	$12.2M	Buy	475,894 +209,143	+78%	+$4.77M	0.07%	167
2020 Q2	$6.85M	Buy	266,751 +120,612	+83%	+$2.44M	0.04%	256
2020 Q1	$2.25M	Buy	146,139 +127,194	+671%	+$2.76M	0.02%	334
2019 Q4	$650K	Buy	+18,945	New	+$227K	﹤0.01%	629